​

Cannabidiol (CBD) in Cancer Management

​

Combination therapy with cannabidiol and chemotherapeutics in canine urothelial carcinoma cells

​

The ECS - A target for cancer treatment

​

Circulating Endocannabinoids in Canine Multicentric Lymphoma Patients

​

Abstract - Anti-proliferative effect of cannabidiol (CBD) against B and-T-cell lymphoma

​

The effect of cannabidiol on canine neoplastic cell proliferation and mitogen-activated protein kinase activation during autophagy and apoptosis

​

Suppression of vascular endothelial growth factor expression by cannabinoids in a canine osteosarcoma cell line​

​

The heterogeneity and complexity of Cannabis extracts as antitumour agents

​

Cannabidiol Induces Apoptosis and Perturbs Mitochondrial Function in both Human and Canine Glioma Cells

​

CP55,940 increases intracellular Ca2+ levels in Madin-Darby canine kidney cells

​

Novel effect of CP55,940, a CB1/CB2 cannabinoid receptor agonist, on intracellular free Ca2+ levels in bladder cancer cells

​

Cannabis Therapeutics and the Future of Neurology

 

GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine | Oncogene

 

Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients

​

Cannabis sativa: The Plant of the Thousand and One Molecules | Plant Science

 

Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation. - PubMed - NCBI

 

Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells

 

Rates of cannabis use in patients with cancer

 

Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression

 

Potentiating effect of beta-caryophyllene on anticancer activity of alpha-humulene, isocaryophyllene and paclitaxel

 

Integrating cannabis into clinical cancer care

 

Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol

 

Endocannabinoids and Cancer

 

Studies on CBD and Cancer

 

Cannabis and Cannabinoids (PDQ®)—Health Professional Version - National Cancer Institute

 

Practical considerations in medical cannabis administration and dosing